COMPOSITION MEDICINALE DESTINEE A AMELIORER OU A TRAITER L'INTOLERANCE AU GLUCOSE, LE PRE–DIABETE, L'INSULINORESISTANCE ET L'HYPERINSULINEMIE ET CONTENANT UN AGENT HYPOGLYCEMIANT- Brevets EP1891971 (A1)

COMPOSITION MEDICINALE DESTINEE A AMELIORER OU A TRAITER L'INTOLERANCE AU GLUCOSE, LE PRE–DIABETE, L'INSULINORESISTANCE ET L'HYPERINSULINEMIE ET CONTENANT UN AGENT HYPOGLYCEMIANT

N° de brevet:	EP1891971 (A1)
Date de publication:	2008-02-27
Inventeur(s):	KITAHARA YOSHIRO [JP];MIURA KYOKO [JP];
Demandeur(s):	AJINOMOTO KK [JP];
Classification:	A61K45/00;A61K31/4045;A61P3/10;A61P9/10;A61P43/00;C07D209/44;
N° de demande:	EP20060712691 20060131
Numéro(s) de priorité:	WO2006JP301548 20060131;JP20050023289 20050131

The present invention provides a pharmaceutical composition containing a hypoglycemic agent(s) as an active ingredient for improving or treating impaired glucose tolerance, borderline diabetes, insulin resistance or hyperinsulinemia. The present invention further provides a pharmaceutical composition for preventing or delaying the progression from impaired glucose tolerance, borderline diabetes, insulin resistance or hyperinsulinemia to diabetes mellitus or metabolic syndromes; or the progression to the state easy to develop macrovascular disorders, cardiovascular events or ischemic heart disease.